New Alzheimer's Drug Donanumab: Approval, Trials, and Challenges

Morning Medical with Dr. Chow · Jul 3, 2024 · 20m · transcript

Dr. Chi-Ming Chow discusses the FDA approval of the new Alzheimer's drug Donanumab, comparing it to Lekembi and addressing its clinical trial results, side effects, and logistical challenges. He also covers the WHO's new clinical treatment guideline for smoking cessation, recommended treatments, and vaping products, along with global and Canadian tobacco use statistics. (0:00) Introduction (0:25) FDA approval of new Alzheimer's drug Donanumab (1:15) Clinical trial results and side effects of Donanumab (2:21) Comparison between Donanumab and Lekembi (3:31) Logistical and financial challenges…